Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Liver Neoplasms × Taxes × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 17 Breast Neoplasms 17 Carcinoma, Non-Small-Cell Lung 15 Ovarian Neoplasms 13 Fallopian Tube Neoplasms 11 Carcinoma, Ovarian Epithelial 9 Unspecified Adult Solid Tumor, Protocol Specific 8 Neoplasm Metastasis 8 Triple Negative Breast Neoplasms 7 Endometrial Neoplasms 6 Brenner Tumor 6 Stomach Neoplasms 5 Lung Neoplasms 5 Esophageal Neoplasms 5 Breast Neoplasms, Male 5 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 4 Melanoma 3 Gallbladder Neoplasms 3 Cholangiocarcinoma 3 Adenocarcinoma of Lung 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Salivary Gland Neoplasms 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Peritoneal Neoplasms 2 Lymphoma, Non-Hodgkin 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Carcinoma, Squamous Cell 2

Interventions

Sorafenib 19 Bevacizumab 6 Oxaliplatin 5 Melphalan 5 Leucovorin 5 Irinotecan 5 Cyclophosphamide 5 pembrolizumab 4 fludarabine 4 Nivolumab 4 Fluorouracil 4 Sirolimus 3 Ipilimumab 3 Gemcitabine 3 Filgrastim 3 Carboplatin 3 Capecitabine 3 toripalimab 2 spartalizumab 2 pazopanib 2 lenvatinib 2 ixabepilone 2 fludarabine phosphate 2 durvalumab 2 atezolizumab 2 Thiotepa 2 Temozolomide 2 Sirtuins 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00732836 2016-02-05

Hepatic Arterial Infusion (HAI) of Abraxane

M.D. Anderson Cancer Center

Phase 1 Completed

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡